Bite Counter = A Pedometer for Your Mouth Count bites by tracking your wrist movement. Researchers have developed a way to fight obesity by helping people answer one fundamental question: how many bites of food are you eating? The Bite Counter, a wristwatch-shaped device being marketed to weight-loss clinics and fitness …

At any given average glucose level, high variability results in higher glycosylated hemoglobin level. In a study involving 427 diabetic patients (63% had type 1 diabetes), investigators obtained about 2700 blood glucose measurements per patient during a 3-month period. Glucose variability affected HbA1c in type 1 diabetic patients. In patients …

According to results of the CREDIT study, increased weight gain occurred among insulin users who had a higher HbA1c at baseline; had a lower BMI; less frequently used concomitant glucose-lowering medications; did not start basal insulin; and were using multiple insulin injection regimens. Additionally, higher insulin dose at 1 year …

Important lessons regarding the implementation of an education program in primary care have been learned and can contribute to a better understanding of the reasons why GPs hesitate to refer patients to a self-management education program. Reasons included: the role of GPs and other health care providers in diabetes care …

Glucose-sensing enzyme holds the key to insulin production, according to breakthrough Israeli research pointing the way towards a possible cure for diabetes. Watch for a special Diabetes In Control interview with Dr. Dor coming soon….

Thorough chewing stimulates the release of 2 intestinal peptides that reduce appetite and food intake in obese individuals, according to the results of a study.…

Adding insulin detemir to a treatment regimen of metformin and liraglutide improved glycemic control and led to sustained weight loss for up to 52 weeks in patients with type 2 diabetes.…

A measure of the postprandial ratio of urinary C-peptide to creatinine (UCPCR) can distinguish maturity-onset diabetes of the young (MODY) from type 1 diabetes mellitus, allowing some children who would otherwise be treated with insulin to receive oral antidiabetic agents alone….

While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetes patients, researchers made a surprising discovery –- treatment with the so-called gliptin class appears to protect the heart.…

New data on two investigational glucagon receptor antagonists suggest that this novel class of drugs has potential to be an effective treatment for type 2 diabetes.…